Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
US NUCLEAR CORP. (UCLE)
|
Add to portfolio |
|
|
|
| Price: |
$0.24
| | Metrics |
| OS: |
36.4
|
M
| |
|
|
| Market cap: |
$8.73
|
M
| |
|
|
|
Net debt:
|
$811.8
|
k
| |
|
|
|
EV:
|
$9.55
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($1.2)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 2.1 | 1.8 | 3.5 | 3.6 | 3.1 | 2.1 | 2.7 | 1.6 |
| Revenue growth | 21.9% | -50.5% | -2.6% | 18.4% | 46.4% | -20.9% | 62.0% | -30.5% |
| Cost of goods sold | 1.8 | 1.3 | 1.6 | 1.7 | 1.7 | 1.3 | 1.2 | 0.9 |
| Gross profit | 0.4 | 0.5 | 1.9 | 1.9 | 1.3 | 0.8 | 1.4 | 0.7 |
| Gross margin | 16.4% | 27.1% | 54.7% | 53.0% | 43.8% | 36.9% | 53.0% | 44.7% |
| Selling, general and administrative | | | | | 1.3 | 1.1 | 1.0 | 1.0 |
| General and administrative | 0.8 | 0.5 | 1.8 | 1.0 | | | | |
| EBITA | -1.4 | -2.1 | -2.5 | -1.3 | 0.2 | -1.5 | 0.4 | -0.3 |
| EBITA margin | -63.7% | -118.9% | -69.5% | -34.5% | 5.3% | -72.0% | 16.0% | -18.6% |
| Amortization of intangibles | | | | 0.1 | 0.1 | 0.1 | | |
| EBIT | -1.4 | -2.1 | -2.5 | -1.3 | 0.0 | -1.6 | 0.4 | -0.3 |
| EBIT margin | -63.7% | -118.9% | -69.5% | -36.0% | 1.1% | -75.6% | 16.0% | -18.6% |
| Pre-tax income | -1.9 | -3.5 | -3.2 | -2.4 | 0.0 | -1.6 | 0.4 | -0.3 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -1.9 | -3.5 | -3.2 | -2.4 | 0.0 | -1.6 | 0.4 | -0.3 |
| Net margin | -90.3% | -201.8% | -89.3% | -66.2% | 0.3% | -76.6% | 15.1% | -19.6% |
| |
| Diluted EPS | ($0.07) | ($0.16) | ($0.17) | ($0.15) | $0.00 | ($0.12) | $0.03 | ($0.03) |
| Shares outstanding (diluted) | 27.4 | 22.1 | 18.3 | 16.0 | 14.0 | 13.6 | 13.3 | 11.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|